Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proliferative activity in thyroid tumors.

A Yoshida1, H Kamma, T Asaga

  • 1Department of Surgery, Kanagawa Cancer Center, Yokohama, Japan.

Cancer
|May 15, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HPC-1 is associated with synaptotagmin and omega-conotoxin receptor.

The Journal of biological chemistry·1992
Same author

[The first cholera case diagnosed early in the clinical laboratory by DNA probe method].

Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases·1992
Same author

Parathyroid hormone inhibits immunoglobulin production without affecting cell growth in human B cells.

Clinical immunology and immunopathology·1992
Same author

Structural differences between heparan sulphates of proteoglycan involved in the formation of basement membranes in vivo by Lewis-lung-carcinoma-derived cloned cells with different metastatic potentials.

The Biochemical journal·1992
Same author

The quality and quantity of dietary protein affect brain protein synthesis in rats.

The Journal of nutrition·1992
Same author

Evaluation of thyroid function in patients with isolated adrenocorticotropin deficiency.

The American journal of the medical sciences·1992
Same journal

Toward exercise as standard care for older cancer survivors.

Cancer·2026
Same journal

Maintenance therapy in gynecologic malignancies: Current and future state.

Cancer·2026
Same journal

Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

Cancer·2026
Same journal

Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

Cancer·2026
Same journal

EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

Cancer·2026
Same journal

Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

Cancer·2026
See all related articles

Papillary thyroid carcinoma proliferation varies with age. Older patients (≥50 years) show higher bromodeoxyuridine (BrdU) labeling index (LI), suggesting age-related biological differences and potentially poorer prognosis in elderly individuals.

Area of Science:

  • Endocrinology
  • Oncology
  • Pathology

Background:

  • Papillary thyroid carcinoma (PTC) is the most common type of thyroid malignancy.
  • Understanding the proliferative activity of PTC is crucial for prognosis and treatment strategies.

Purpose of the Study:

  • To investigate the proliferative activity of papillary thyroid carcinoma using bromodeoxyuridine (BrdU) labeling index (LI).
  • To explore the correlation between PTC proliferative activity and patient age, as well as other prognostic factors.

Main Methods:

  • In vitro bromodeoxyuridine (BrdU) labeling technique.
  • Immunohistochemical staining with anti-BrdU monoclonal antibody.
  • Analysis of LI in 61 various thyroid tumors, including 31 papillary carcinomas.

Related Experiment Videos

Main Results:

  • The mean LI for papillary carcinomas was 1.2% (+/- 1.3%), with a range of 0.1% to 4.6%.
  • Approximately 66% of papillary carcinomas showed LI < 1%, similar to benign thyroid tumors.
  • A positive correlation was observed between PTC LI and patient age, with patients ≥50 years old tending to have higher LI.

Conclusions:

  • Papillary thyroid carcinoma exhibits variable biological characteristics influenced by patient age.
  • Higher proliferative activity in older patients may be associated with a poorer prognosis for papillary thyroid carcinoma.